ES494891A0 - Procedimiento de preparacion de compuestos 1(2h)-isoquinolo-nicos y similares - Google Patents

Procedimiento de preparacion de compuestos 1(2h)-isoquinolo-nicos y similares

Info

Publication number
ES494891A0
ES494891A0 ES494891A ES494891A ES494891A0 ES 494891 A0 ES494891 A0 ES 494891A0 ES 494891 A ES494891 A ES 494891A ES 494891 A ES494891 A ES 494891A ES 494891 A0 ES494891 A0 ES 494891A0
Authority
ES
Spain
Prior art keywords
isoquinolo
nicos
compounds
procedure
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES494891A
Other languages
English (en)
Spanish (es)
Other versions
ES8106501A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Maruko Pharmaceutical Co Ltd
Taiho Pharmaceutical Co Ltd
Original Assignee
Maruko Pharmaceutical Co Ltd
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maruko Pharmaceutical Co Ltd, Taiho Pharmaceutical Co Ltd filed Critical Maruko Pharmaceutical Co Ltd
Publication of ES8106501A1 publication Critical patent/ES8106501A1/es
Publication of ES494891A0 publication Critical patent/ES494891A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ES494891A 1979-08-21 1980-08-21 Procedimiento de preparacion de compuestos 1(2h)-isoquinolo-nicos y similares Granted ES494891A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10549779A JPS5677261A (en) 1979-08-21 1979-08-21 1 2h isoquinolone derivative and its acid addition salt

Publications (2)

Publication Number Publication Date
ES8106501A1 ES8106501A1 (es) 1981-09-01
ES494891A0 true ES494891A0 (es) 1981-09-01

Family

ID=14409228

Family Applications (1)

Application Number Title Priority Date Filing Date
ES494891A Granted ES494891A0 (es) 1979-08-21 1980-08-21 Procedimiento de preparacion de compuestos 1(2h)-isoquinolo-nicos y similares

Country Status (10)

Country Link
JP (1) JPS5677261A (it)
AU (1) AU532023B2 (it)
CA (1) CA1153763A (it)
CH (1) CH646953A5 (it)
DE (1) DE3031574A1 (it)
ES (1) ES494891A0 (it)
FR (1) FR2463766A1 (it)
GB (1) GB2058783B (it)
IT (1) IT1188988B (it)
NL (1) NL8004736A (it)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2098980B (en) * 1981-03-28 1985-05-15 Taiho Pharmaceutical Co Ltd 1(2h)-isoquinolone compounds and acid addition salts thereof
JPS58164577A (ja) * 1982-03-24 1983-09-29 Taiho Yakuhin Kogyo Kk 4―ベンジル―1―(2h)イソキノロン誘導体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3600394A (en) * 1968-05-17 1971-08-17 Searle & Co 2-aminoalkyl-3-arylisocarbostyrils
SE368009B (it) * 1971-09-16 1974-06-17 Kabi Ab
US3928612A (en) * 1974-10-02 1975-12-23 American Home Prod 1,2-Dihydro- and 1,2,3,4-tetrahydro-1-oxo-3-isoquinolinecarboxylic acid derivatives as anti-allergic agents

Also Published As

Publication number Publication date
DE3031574A1 (de) 1981-03-12
CA1153763A (en) 1983-09-13
AU532023B2 (en) 1983-09-15
AU6160980A (en) 1981-04-09
FR2463766A1 (fr) 1981-02-27
GB2058783A (en) 1981-04-15
FR2463766B1 (it) 1983-09-02
ES8106501A1 (es) 1981-09-01
GB2058783B (en) 1983-04-07
CH646953A5 (de) 1984-12-28
IT8049519A1 (it) 1982-02-19
IT1188988B (it) 1988-01-28
JPS5677261A (en) 1981-06-25
NL8004736A (nl) 1981-02-24
IT8049519A0 (it) 1980-08-19

Similar Documents

Publication Publication Date Title
NO801155L (no) Fremgangsmaate ved fremstilling av acyl-carnitinamider
NO149389C (no) Fremgangsmaate til fremstilling av 4,1`,6`-triklor-4,1`,6`-trideoksy-galaktosukrose
NO800830L (no) Fremgangsmaate ved fremstilling av glycinamidderivater
NO802913L (no) Fremgangsmaate ved fremstilling av cephalosporinforbindelse
NO802196L (no) Fremgangsmaate for fremstilling av diester-diamider
NO150156C (no) Fremgangsmaate ved fremstilling av 5(6)-thio-benzimidazolderivater
NO820281L (no) Fremgangsmaate ved fremstilling av n-(halogenmethyl)-acylamider
JPS5668645A (en) Manufacture of 2*66dialkylcyclohexylamine
NO802834L (no) Fremgangsmaate ved fremstilling av 2-amino-3-benzoyl-fenylacetamider
GB2051119B (en) Preparation of 2 3-dimethylbutene-2
AR223703A1 (es) Un procedimiento de preparacion de un trihalometil-carbonato alcalino y cicloalquil-derivado y dicho compuesto
JPS55143942A (en) Manufacture of 2**6**dialkyllnnalkoxymethyll 22chlorooacetoanilide
JPS5640620A (en) Manufacture of 1*22dichloroethane
JPS5692898A (en) Manufacture of 4*1**6**trichloroo4*1**6** trideoxygalactosucrose
IT1125604B (it) Procedimento per la preparazione di n-fenil-n'-alchilfenilendiammine
JPS55164634A (en) Manufacture of 1*22dichloroethane
ES494891A0 (es) Procedimiento de preparacion de compuestos 1(2h)-isoquinolo-nicos y similares
JPS55154960A (en) Manufacture of 55mercaptoo1*2*33triazole
JPS55154926A (en) Manufacture of 1*3*55trichlorobenzene
JPS5616428A (en) Manufacture of 1*11dichloroalkene
JPS5615224A (en) Manufacture of 2*22dichloroo55methyll1*1*11 trifluorohexenee44ene
JPS5636469A (en) Manufacture of 1*2*44triazole
NO773463L (no) Fremgangsmaate ved fremstilling av n-(2`-furanidyl)-5-fluor-uracil
NO802348L (no) Fremgangsmaate til fremstilling av 1-grenet-alkyl-3-(2-haloetyl)-3-nitrosokarbamider
TR20895A (tr) 1,2,3-tiyadiyazol-5-yl uerelerinin hazirlanmasina mahsus usul